QDEL vs BFLY vs CV Stock Comparison

QuidelOrtho, Butterfly Network and CapsoVision Prices as of Nov 4, 2026 Peers: Industry group
1 more company in this comparison (GEHC) Create a free account to keep reading and compare up to 10 companies.
QDEL QuidelOrtho Corp
$14.35 +18.2% 1M -47.1% 1Y
Market cap
$980.11M
P/E
–
Revenue (TTM)
-$211.90M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
BFLY Butterfly Network, Inc.
$6.77 -27.8% 1M +158.4% 1Y
Market cap
$1.66B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
6 wins
CV CapsoVision, Inc
$6.85 +3.9% 1M +49.2% 1Y
Market cap
$342.72M
P/E
–
Revenue (TTM)
$13.89M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Butterfly Network leads on 6 of the 12 questions below (Butterfly Network 6, QuidelOrtho 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionQDELBFLYCVLeader
Larger companyMarket capitalisation $980.11M $1.66B $342.72M BFLY
Cheaper on earningsLower P/E, profitable companies only -0.9x -33.1x -11.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.1x — — –
Faster revenue growthRevenue growth, trailing twelve months -30.8% +39.4% +11.0% BFLY
More profitableNet margin, trailing twelve months — -43.6% -214.7% BFLY
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield — — 0.00% –
Better 1-year returnPrice return, last 12 months -47.1% +158.4% +49.2% BFLY
Better 5-year returnAnnualised price return, 5 years -34.7%/yr -8.3%/yr — BFLY
Less volatileAnnualised volatility, 1 year 93.2% 112.3% 95.9% QDEL
Higher overall scoreMean of the five percentile scores vs peers 23/100 50/100 29/100 BFLY

Percentile Scorecard

QDELBFLYCV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisQDELBFLYCV
Valuation 46 #125 of 229 29 #162 of 229 11 #205 of 229
Growth 1 #219 of 221 89 #25 of 221 22 #173 of 221
Profitability – 38 #130 of 209 22 #163 of 209
Financial Health 11 #215 of 240 57 #103 of 240 77 #56 of 240
Shareholder Returns 36 #94 of 146 37 #92 of 146 16 #123 of 146
Overall 23 50 29
  • QDEL ranked among 248 companies in Medical Devices and Diagnostics
  • BFLY ranked among 248 companies in Medical Devices and Diagnostics
  • CV ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodQDELBFLYCVSPY
1 month +18.2%-27.8%+3.9% -1.0%
3 months -18.0%-19.6%+1.2% -0.4%
6 months +30.9%+48.8%-2.3% +4.5%
Year to date -49.8%+78.2%-35.9% +12.4%
1 year -47.1%+158.4%+49.2% +13.6%
3 years -77.7%+504.5%— +76.4%
3 years, per year -39.4%+82.2%— +20.8%
5 years -88.2%-35.1%— +63.7%
5 years, per year -34.7%-8.3%— +10.4%
10 years -23.6%—— +267.7%
10 years, per year -2.7%—— +13.9%

Risk

MeasureQDELBFLYCVSPY
Volatility, 1Y 93.2%112.3%95.9% 12.8%
Downside volatility, 1Y 101.1%93.4%89.1% 12.7%
Beta vs S&P 500, 1Y 2.573.040.62 1.00
Return / volatility, 1Y -0.511.410.51 1.06
Max drawdown, 5Y -94.3%-93.3%-67.8% -25.4%
From 52-week high -59.4%-31.9%-52.5% -1.6%
52-week high $35.38$9.94$14.42 $779.14
52-week low $9.96$1.97$4.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleQDELBFLYCV
P/E now vs peer median -0.9xmedian 28.5x -33.1xmedian 28.5x -11.5xmedian 28.5x
P/S now vs peer median -4.6xmedian 2.9x 13.5xmedian 2.9x 24.7xmedian 2.9x
EV/EBITDA now vs peer median —median 18.5x -30.3xmedian 18.5x -11.4xmedian 18.5x
P/FCF now vs peer median -4.6xmedian 26.7x -60.4xmedian 26.7x -12.3xmedian 26.7x
P/B now vs peer median 0.6xmedian 2.3x 9.0xmedian 2.3x 26.0xmedian 2.3x
PEG now vs peer median 0.01median 0.93 -1.10median 0.93 —median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsQDELBFLYCV
Revenue -$211.90M $123.25M $13.89M
Gross profit – $86.60M $7.07M
Operating income – -$57.83M -$30.16M
Net income -$1.05B -$53.69M -$29.83M
Free cash flow -$211.20M -$27.55M -$27.89M
R&D – $39.57M $21.56M
EPS (diluted) $-15.35 $-0.20 $-0.60
Cash & equivalents $123.40M $122.30M –
Total debt $2.89B – –
Shares (diluted) 68.30M 262.10M 49.94M
Enterprise value $448.41M $1.13B $342.72M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricQDELBFLYCV
P/E -0.9x -33.1x -11.5x
P/FCF -4.6x -60.4x -12.3x
P/Operating cash flow -17.1x -71.2x -12.3x
P/S -4.6x 13.5x 24.7x
P/B 0.6x 9.0x 26.0x
P/Tangible book -1.1x 9.4x 26.0x
EV/EBITDA – -30.3x -11.4x
EV/EBIT – -26.7x -11.4x
EV/Revenue -17.7x 12.5x 24.7x
EV/FCF -17.7x -56.0x -12.3x
EV/Operating cash flow -65.5x -65.9x -12.3x
PEG (3Y EPS CAGR) 0.01 -1.10 –

Growth

14 metrics
MetricQDELBFLYCV
Revenue growth (1Y) -30.8% 39.4% 11.0%
Revenue CAGR (3Y) -27.0% 21.7% –
Gross profit growth (1Y) – 126.4% 5.6%
Gross profit CAGR (3Y) – 30.5% –
Operating income growth (1Y) – 33.5% -47.3%
Operating income CAGR (3Y) – 26.9% –
Net income growth (1Y) -124.8% 32.8% -46.0%
Net income CAGR (3Y) -107.7% 24.2% –
EPS growth (1Y) -122.8% 35.4% 93.3%
EPS CAGR (3Y) -106.5% 30.0% –
Operating cash flow growth (1Y) -128.5% 5.8% -26.6%
Operating cash flow CAGR (3Y) -27.1% 41.1% –
Free cash flow growth (1Y) -1,725% -0.1% -26.5%
Free cash flow CAGR (3Y) -30.1% 38.8% –

Profitability

14 metrics
MetricQDELBFLYCV
Gross margin – 70.3% 50.9%
EBITDA margin – -41.4% -215.5%
Operating margin – -46.9% -217.1%
Pretax margin – -43.5% -214.6%
Net margin – -43.6% -214.7%
FCF margin – -22.4% -200.8%
Operating cash flow margin 27.0% -19.0% -200.3%
Return on equity – -28.7% -178.7%
Return on assets – -18.8% -134.0%
Return on invested capital – – –
Return on capital employed – -26.6% -176.4%
Asset turnover 0.0x 0.4x 0.6x
Cash conversion (OCF / net income) 0.1x 0.4x 0.9x
Stock comp / revenue -20.9% 20.8% 10.2%

Financial Health

11 metrics
MetricQDELBFLYCV
Debt / assets 50.6% – –
Debt / equity 1.6x – –
Net debt / EBITDA – – –
Debt / FCF -13.7x – –
Liabilities / assets 68.9% 36.0% 29.1%
Equity / assets 31.1% 64.0% 70.9%
Interest coverage – -46.8x –
Current ratio 1.4x 3.6x 3.4x
Quick ratio 0.5x 2.3x –
Cash ratio 0.1x 1.8x –
Altman Z-score – 5.68 21.40

Shareholder Returns

7 metrics
MetricQDELBFLYCV
Dividend yield – – –
Net buyback yield -0.5% -0.5% -11.9%
Shareholder yield -0.5% -0.5% -11.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusQDELBFLYCV
Forward P/E 19.1xFY2026 – –
EPS, next fiscal year $0.75FY2026 $-0.10FY2026 $-0.58FY2026
EPS growth, next FY -64.6%FY2026 – –
EPS growth, the year after +101.3% – –
Revenue, next fiscal year $2.67BFY2026 $114.50MFY2026 $13.91MFY2026
Revenue growth, next FY -2.0%FY2026 +17.3%FY2026 +2.7%FY2026
Revenue growth, the year after +0.2% +26.0% +46.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersQDELBFLYCV
Held by institutions 100.0% 58.4% 10.2%
Institutions holding 243 248 50
Change in shares held, QoQ +2.9% +13.9% +27.6%
Institutions buying 143 144 36
Institutions selling 65 59 8
Buyers to sellers 2.20 2.44 4.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

QDELBFLYCV
QDEL 1.00 0.24 0.19
BFLY 0.24 1.00 0.07
CV 0.19 0.07 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, QDEL, BFLY and CV?

Butterfly Network (BFLY) is the largest by market capitalisation: QuidelOrtho (QDEL) $980.11M, Butterfly Network (BFLY) $1.66B, CapsoVision (CV) $342.72M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: QuidelOrtho (QDEL) -30.8%, Butterfly Network (BFLY) +39.4%, CapsoVision (CV) +11.0%.

Which company is more profitable?

Butterfly Network (BFLY) has the highest net margin (Butterfly Network (BFLY) -43.6%, CapsoVision (CV) -214.7%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: QuidelOrtho (QDEL) -47.1%, Butterfly Network (BFLY) +158.4%, CapsoVision (CV) +49.2%. Over five years, Butterfly Network (BFLY) compounded fastest (QuidelOrtho (QDEL) -34.7%/yr, Butterfly Network (BFLY) -8.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, QuidelOrtho (QDEL) has been the steadiest (QuidelOrtho (QDEL) 93.2%, Butterfly Network (BFLY) 112.3%, CapsoVision (CV) 95.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, QDEL, BFLY and CV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.